Biolevox HA pre-filled syringes with hyaluronic acid molecules

Biolevox™ HA

Hialuronic acid with proven clinical effectiveness.

Biolevox™ HA Family

Different variants of Biolevox™ HA with carefully selected parameters of HA dedicated for targeted injection therapies

  • Biolevox™ HA ONE

    Single-injection hyaluronic acid therapy

    Biolevox HA ONE pre-filled syringe with hyaluronic acid molecules
    More

  • Biolevox™ HA 2,2%

    Three-injection hyaluronic acid therapy

    Biolevox HA 2,2 percent pre-filled syringe with hyaluronic acid molecules
    More

  • Biolevox™ HA mini

    Hyaluronic acid treatment for small joints

    Biolevox HA mini pre-filled syringe with hyaluronic acid molecules
    More

  • Biolevox™ HA Tendon

    DKK-1 rich blood-derived preparation kit.

    Biolevox HA Tendon pre-filled syringe with hyaluronic acid molecules
    More

Biolevox™ Performance

Hyaluronic acid therapy for better joint and tendon health.

Biolevox HA syringe surrounded by hyaluronic acid bubbles

  • Clinically Effective Performance

    Biolevox™ HA is backed by clinical efficacy to reduce pain and support active tissue repair. It effectively restores mobility and accelerates recovery in both joint osteoarthritis and tendon injuries.

  • Tailored Viscosity & Concentration

    Formulated with specific concentrations and viscosity levels tailored to distinct clinical conditions. This targeted approach precisely optimizes synovial fluid quality and delivers maximum therapeutic benefits where needed most.

  • Optimally High Molecular Weight

    Features an optimal high molecular weight profile to provide superior cushioning, lubrication, and tissue protection, ensuring enhanced joint durability and faster restoration of functional movement.

Direct benefits for patients

Less pain, better joint mobility, and support for tendon recovery.

  • Reduced pain

    • Sustained relief from joint pain and discomfort
    • Greater pain reduction than corticosteroids

  • Improved joint function

    • Enhanced joint lubrication, better mobility
    • Reduced stiffness, smoother movement

  • Cartilage protection

    • Lubricant and shock absorber, reducing friction
    • Supports chondrocyte growth

  • Tendon support

    • Supports tissue repair and gliding in tendons and entheses
    • Faster recovery from tendinopathy

Engineered for movement

Biolevox™ HA combines precisely selected hyaluronic acid parameters with clinically focused formulations designed to support joint function across different therapeutic needs. With variations in concentration, viscosity and molecular weight, the Biolevox™ HA family delivers targeted viscosupplementation for a broad range of joints and clinical conditions.

Your questions, answered

FAQs

What accounts for the differences in the parameters of the Biolevox™ HA ONE and Biolevox™ HA 2.2 preparations?

This stems from the different treatment regimen and the adjustment of the product’s parameters to the number of injections. Biolevox™ HA ONE is intended for a single intra-articular injection. It contains 120 mg of hyaluronic acid in 4.8 ml, with a concentration of 2.5% and a molecular weight of 1.8 to 3.2 MDa. Biolevox™ HA 2.2% is intended for a treatment course consisting of three intra-articular injections administered at 7-day intervals. It contains 44 mg of hyaluronic acid in 2 ml, with a concentration of 2.2% and a molecular weight of 1.4 to 2.4 MDa. Differences in volume, dosage, concentration, viscosity, and molecular weight affect the product’s viscoelastic properties, the comfort of administration, and the total dose of HA delivered during the treatment course.

What are the differences in the application of the two products?

Content to be supplied.

Is higher hyaluronic acid viscosity better?

Content to be supplied.

Does a higher molecular weight result in a better clinical effect?

Content to be supplied.

Into which joints can Biolevox™ HA be administered?

Content to be supplied.